Literature DB >> 18957543

Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells.

I Zucchi1, S Astigiano, G Bertalot, S Sanzone, C Cocola, P Pelucchi, G Bertoli, M Stehling, O Barbieri, A Albertini, H R Schöler, B G Neel, R A Reinbold, R Dulbecco.   

Abstract

Tumors derived from rat LA7 cancer stem cells (CSCs) contain a hierarchy of cells with different capacities to generate self-renewing spheres and tubules serially ex vivo and to evoke tumors in vivo. We isolated two morphologically distinct cell types with distinct tumorigenic potential from LA7-evoked tumors: cells with polygonal morphology that are characterized by expression of p21/(WAF1) and p63 and display hallmarks of CSCs and elongated epithelial cells, which generate tumors with far less heterogeneity than LA7 CSCs. Serial transplantation of elongated epithelial cells results in progressive loss of tumorigenic potential; tumor heterogeneity; CD44, E-cadherin, and epithelial cytokeratin expression and increased alpha-smooth muscle actin I and vimentin expression. In contrast, serial transplantation of LA7 CSCs can be performed indefinitely and results in tumors that maintain their heterogeneity, consistent with self-renewal and multilineage differentiation potential. Collectively, our data show that polygonal cells are CSCs, whereas epithelial elongated cells are lineage-committed progenitors with tumorigenic potential, and suggest that tumor progenitors, although lacking indefinite self-renewal potential, nevertheless may make a substantial contribution to tumor development. Because LA7 cells can switch between conditions that favor maintenance of pure CSCs vs. differentiation into other tumor cell types, this cell system provides the opportunity to study factors that influence CSC self-renewal and differentiation. One factor, p63, was identified as a key gene regulating the transition between CSCs and early progenitor cells.

Entities:  

Mesh:

Year:  2008        PMID: 18957543      PMCID: PMC2575224          DOI: 10.1073/pnas.0808978105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

2.  Purification and unique properties of mammary epithelial stem cells.

Authors:  John Stingl; Peter Eirew; Ian Ricketson; Mark Shackleton; François Vaillant; David Choi; Haiyan I Li; Connie J Eaves
Journal:  Nature       Date:  2006-01-04       Impact factor: 49.962

3.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

4.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 5.  Stem cells in mammary development and carcinogenesis: implications for prevention and treatment.

Authors:  Gabriela Dontu; Suling Liu; Max S Wicha
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 6.  Stromal fibroblasts in cancer: a novel tumor-promoting cell type.

Authors:  Akira Orimo; Robert A Weinberg
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

7.  Isolation of neural stem cells from the postnatal cerebellum.

Authors:  Audra Lee; Jessica D Kessler; Tracy-Ann Read; Constanze Kaiser; Denis Corbeil; Wieland B Huttner; Jane E Johnson; Robert J Wechsler-Reya
Journal:  Nat Neurosci       Date:  2005-05-22       Impact factor: 24.884

Review 8.  Cancer stem cells: models and concepts.

Authors:  Piero Dalerba; Robert W Cho; Michael F Clarke
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

9.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

10.  Identification and expansion of human colon-cancer-initiating cells.

Authors:  Lucia Ricci-Vitiani; Dario G Lombardi; Emanuela Pilozzi; Mauro Biffoni; Matilde Todaro; Cesare Peschle; Ruggero De Maria
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

View more
  8 in total

Review 1.  Aiming to immune elimination of ovarian cancer stem cells.

Authors:  Jiabo Di; Tjitske Duiveman-de Boer; Carl G Figdor; Ruurd Torensma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

2.  The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.

Authors:  Lakshmanane Boominathan
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

3.  Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation.

Authors:  Min Pan; Michael A Reid; Xazmin H Lowman; Rajan P Kulkarni; Thai Q Tran; Xiaojing Liu; Ying Yang; Jenny E Hernandez-Davies; Kimberly K Rosales; Haiqing Li; Willy Hugo; Chunying Song; Xiangdong Xu; Dustin E Schones; David K Ann; Viviana Gradinaru; Roger S Lo; Jason W Locasale; Mei Kong
Journal:  Nat Cell Biol       Date:  2016-09-12       Impact factor: 28.824

4.  Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

Authors:  Sherif A Ibrahim; Hebatallah Hassan; Laura Vilardo; Sampath Katakam Kumar; Archana Vijaya Kumar; Reinhard Kelsch; Cornelia Schneider; Ludwig Kiesel; Hans Theodor Eich; Ileana Zucchi; Rolland Reinbold; Burkhard Greve; Martin Götte
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.

Authors:  Omolola R Oyenihi; Annadie Krygsman; Nicolette Verhoog; Dalene de Beer; Michael J Saayman; Thys M Mouton; Ann Louw
Journal:  Front Pharmacol       Date:  2018-06-20       Impact factor: 5.810

6.  Identification of functionally related genes using data mining and data integration: a breast cancer case study.

Authors:  Ettore Mosca; Gloria Bertoli; Eleonora Piscitelli; Laura Vilardo; Rolland A Reinbold; Ileana Zucchi; Luciano Milanesi
Journal:  BMC Bioinformatics       Date:  2009-10-15       Impact factor: 3.169

7.  A Versatile Tool for Stable Inhibition of microRNA Activity.

Authors:  Paride Pelucchi; Valeria Tria; Valentina Martino; Davood Sabour; Giovanni Bertalot; Stefano Molgora; Mira Palizban; Martin Götte; Ileana Zucchi; Rolland A Reinbold
Journal:  Biology (Basel)       Date:  2013-06-28

8.  Tumor suppressor RBM24 inhibits nuclear translocation of CTNNB1 and TP63 expression in liver cancer cells.

Authors:  Sung Ung Moon; Jang Hyun Kim; Hyun Goo Woo
Journal:  Oncol Lett       Date:  2021-07-19       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.